AIMP1 Protein May Be Promising Biomarker for NMOSD, Study Shows
People with neuromyelitis optica spectrum disorder (NMOSD) have elevated levels of the pro-inflammatory protein AIMP1 in the bloodstream, and higher levels seem to correlate with worse disability, a study showed. These AIMP1 levels dropped markedly after anti-inflammatory therapy, but still remained higher among patients in remission than in people…